Expression of the 5T4 oncofoetal antigen in renal cell carcinoma: a potential target for T-cell-based immunotherapy
Author:
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology
Link
http://www.nature.com/articles/6602776.pdf
Reference43 articles.
1. Antony PA, Restifo NP (2005) CD4+CD25+ T regulatory cells, immunotherapy of cancer, and interleukin-2. J Immunother 28 (2): 120–128
2. Atzpodien J, Royston P, Wandert T, Reitz M, DGCIN – German Cooperative Renal Carcinoma Chemo-Immunotherapy Group (2003) Metastatic renal carcinoma comprehensive prognostic system. Br J Cancer 88: 348–353, doi:10.1038/sj.bjc.6600768
3. Bleumer I, Knuth A, Oosterwijk E, Hofmann R, Varga Z, Lamers C, Kruit W, Melchior S, Mala C, Ullrich S, De Mulder P, Mulders PF, Beck J (2004) A phase II trial of chimeric monoclonal antibody G250 for advanced renal cell carcinoma patients. Br J Cancer 90 (5): 985–990, doi:10.1038/sj.bjc.6601617
4. Cancer Registration Statistics (2001) Vol. 32. UK Office of National Statistics
5. Carsberg CJ, Myers KA, Evans GS, Allen TD, Stern PL (1995) Metastasis-associated 5T4 oncofoetal antigen is concentrated at microvillus projections of the plasma membrane. J Cell Sci 108: 2905–2916
Cited by 66 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Evolution of cell therapy for renal cell carcinoma;Molecular Cancer;2024-01-09
2. Immunohistochemical Detection of 5T4 in Renal Cell Carcinoma;Applied Immunohistochemistry & Molecular Morphology;2023-02-06
3. Renal cell carcinoma pathology in 2021: ‘new need for renal cancer immune profiling’;Current Opinion in Urology;2021-03-11
4. Current Advance of Immune Evasion Mechanisms and Emerging Immunotherapies in Renal Cell Carcinoma;Frontiers in Immunology;2021-03-09
5. Current status of antigen-specific T-cell immunotherapy for advanced renal-cell carcinoma;Human Vaccines & Immunotherapeutics;2021-03-05
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3